Option chain shows key data for Compass Therapeutics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Compass Therapeutics.

Compass Therapeutics (NASDAQ:CMPX) Stock, Option Chain

Compass Therapeutics

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.

News

Penny Stocks

Small Cap

Pre-Market Outlook

Markets

Movers

Trading Ideas

ADTX

ADXN

AMTI

ARAV

BTTR

CMPX

CRKN

EDBL

EFSH

HRYU

HSDT

MEDS

NXGN

RELI

UPTD

WORX

Gainers


	Helius Medical Technologies, Inc. (NASDAQ: HSDT) rose 65.3% to $12.20 in pre-market trading after gaining around 9% on Friday.


Why NextGen Healthcare Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket

Intraday Update

AHPI

AIMD

ALLR

ARMP

AXLA

BBBY

BBCP

BIAF

BXRX

CBAY

CVKD

CYTO

DPRO

ERYP

GROM

HLBZ

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

Intelligent Bio Solutions Inc. - Common Stock

INBS

KRBP

LGMK

NVOS

OTRK

SatixFy Communications Ltd. Ordinary Share

SATX

SAVA

SCLX

SLNH

SNMP

SRNE

TENX

VERB

WISA

Gainers


	Baudax Bio, Inc.  (NASDAQ: BXRX) shares surged 59.7% to $5.03 after the company announced the outcome of its first interim analysis in a Phase II trial of BX1000 for neuromuscular blockade in patients undergoing elective surgery.


Why Baudax Bio Shares Are Trading Higher By 60%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

Earnings

Eurozone

Commodities

Global

BSET

U.S. stocks traded lower this morning, with the Dow Jones dropping more than 100 points on Tuesday.

Following the market opening Tuesday, the Dow traded down 0.31% to 33,524.12 while the NASDAQ fell 0.11% to 11,352.46. The S&amp;P 500 also fell, dropping, 0.30% to 4,007.66.

Dow Drops 100 Points; Verizon Issues Weak Earnings Forecast

Compass Therapeutics, Inc. - Common Stock

Compass Therapeutics Inc

BCTX

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

BCTXW

ENVB

A federal judge in the District of Columbia on Tuesday afternoon temporarily blocked an executive order given by President Donald Trump that imposed a freeze of all federal grants and loans, putting $3 trillion in funding in jeopardy and <a href="https://www.benzinga.com/25/01/43290381/trumps-federal-spending-freeze-puts-3-trillion-in-limbo-threatens-industries-like-clean-energy-defense-healthcare">entire industries on edge.&nbsp;</a>
The Details: According to a New York Times <a href="https://www.nytimes.com/2025/01/28/us/politics/trump-funding-freeze-blocked.html">report</a>, Judge Loren AliKhan blocked the order late Tuesday afternoon in response to a lawsuit filed by Democracy Forward. The lawsuit argued the directive violated the First Amendment and the Administrative Procedures Act governing the issuance of executive orders. 
Judge AliKhan said she will issue a more permanent decision on Feb. 3 
Read Next: <a href="https://www.benzinga.com/news/large-cap/25/01/43106379/trump-reverses-bidens-ai-policies-on-day-1-what-it-means-for-tech-giants-nvidia-amd-alphabet">Trump Reverses Biden&#8217;s AI Policies On Day 1: What It Means For Tech Giants Nvidia, AMD, Alphabet&nbsp;</a>
Skye Perryman, Democracy Forward's president and chief executive, commented on the judge's decision in a statement.&nbsp;
"We are grateful for this administrative stay to allow our clients time to sort through the chaos created by the Trump administration's hasty and ill-advised actions," Perryman said, per the New York Times. 
Trump's directive, issued Monday by the Office of Management and Budget, required federal agencies to halt disbursements while programs were reviewed for alignment with Trump administration policies and was slated to go into effect on Tuesday at 5 p.m. ET.&nbsp;
But, early Tuesday, state Medicaid programs reported the federal reimbursement portals had been locked. State officials said funding for community health centers, food for families, housing assistance, preschools and disaster relief was in limbo.
According to the New York Times, the White House and OMB said on Tuesday afternoon the funding freeze did "not apply across-the-board" and affected programs on D.E.I. efforts and funding for organizations "that undermine the national interest."
Stocks To Watch: It remains unclear exactly which industries could be affected by Trump's order or if the judge will elect to block it permanently on Feb 3.&nbsp;
However, Medicaid funding had reportedly been stopped at least temporarily. HCA Healthcare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) and Universal Health Services Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) stocks fell on Tuesday. 
Large defense contractors like RTX Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) and Lockheed Martin Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) also face a growing degree of uncertainty regarding government funding and contracts.
Green industries including solar energy could also be on the chopping block for federal funding due to Trump administration policies. Sunnova Energy International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOVA#NYSE">NOVA</a>) dropped 12% Tuesday and Sunrun, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>) fell 9.2% amid the uncertainty on future policy changes. 
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/25/01/43287988/microsoft-q2-preview">Microsoft Q2 Earnings Preview: Street &#8216;Too Optimistic&#8217; On Near-Term AI Returns?&nbsp;</a></li>
</ul>
Photo: Shutterstock

Government

Regulations

Health Care

Politics

Legal

General

NOVA

Judge Blocks Trump's Order To Freeze Federal Grant Money

Sen. Bernie Sanders pulled no punches when critiquing Donald Trump&#8217;s recent inaugural address, calling out the former president for failing to address key issues affecting working families in America. In a <a href="https://x.com/SenSanders/status/1881826224819114315">video</a> posted after the event, Sanders expressed his frustration with Trump&#8217;s speech, saying it ignored the real challenges millions of Americans face every day, adding, &#8220;How crazy is that?&#8221;
&#8220;I was at the Trump inauguration yesterday and needless to say, I disagree with much of what he had to say. But what really struck me, however, is not what he said, which was not surprising given his rhetoric, but what he didn't say,&#8221; Sanders stated.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">I attended Trump's inauguration yesterday. Here are my thoughts: <a href="https://t.co/7ZIsTdF5Ui">pic.twitter.com/7ZIsTdF5Ui</a>
&mdash; Bernie Sanders (@SenSanders) <a href="https://twitter.com/SenSanders/status/1881826224819114315?ref_src=twsrc%5Etfw">January 21, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/are-you-rich-2">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
<li><a href="https://www.benzinga.com/money/planning-your-retirement-new-changes-to-social-security-in-2025-could-affect-you">Planning Your Retirement? New Changes To Social Security In 2025 Could Affect You</a></li>
</ul>
<h2 class="wp-block-heading">Sanders: Trump Ignored Healthcare, Housing and Inequality</h2>
One of Sanders&#8217; main points of contention was Trump's complete omission of the health care<a href="https://www.benzinga.com/partner/health-care/24/04/38378856/90-of-americans-believe-we-are-experiencing-a-mental-health-care-crisis-elevate-health-and-we"> crisis</a>. Sanders emphasized that millions of Americans struggle to afford basic medical care while prescription drug prices remain astronomically high.
&#8220;Our health care system is broken, is dysfunctional and it's wildly expensive,&#8221; he said. &#8220;Not one word from Trump about how he is going to address the health care crisis. We pay by far the highest prices in the world for prescription drugs, sometimes 10 times more than the people in other countries. Not one word in his speech on the high cost of prescription drugs.&#8221;
Trending: ‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a>
Sanders also highlighted the growing housing crisis in America, where millions are either homeless or spending the <a href="https://www.benzinga.com/real-estate/24/11/41811635/rent-soars-pay-lags-why-millions-are-working-50-hours-just-to-afford-housing-according-to-new-report">majority of their income</a> just to keep a roof over their heads. &#8220;We have a major housing crisis in America. Everybody knows it. And Trump, in his inaugural address, did not devote one word to it,&#8221; Sanders pointed out.
However, Trump did mention in his speech that he would direct all members of his cabinet to &#8220;marshal the vast powers at their disposal to defeat what was record inflation and rapidly bring down costs and prices.&#8221; He also mentioned that the inflation crisis was &#8220;caused by massive overspending and escalating energy prices,&#8221; and that&#8217;s why he would &#8220;also declare a national energy emergency.&#8221;
Trending: They're saying this is the biggest breakthrough in Next-Gen Tech since the iPhone. <a href="https://www.benzinga.com/money/elf-labs-1">There&#8217;s now a limited window for investors to claim shares at just $2/share with $980 minimum—but the clock is ticking.</a>
<h2 class="wp-block-heading">Income Inequality and Climate Change Also Missing</h2>
According to Sanders, another glaring omission was any mention of income inequality. He noted that the wealthiest three Americans now hold more wealth than the bottom half of the population combined. &#8220;The wealthiest three people in America now own more wealth than the bottom half of our society.&#8221;
Sanders took particular issue with the fact that these <a href="https://www.benzinga.com/markets/equities/25/01/43078874/elon-musk-jeff-bezos-mark-zuckerberg-among-those-in-race-to-become-first-trillionaires-oxfam-warns-of-growing-wealth-inequality">three billionaires saw their wealth grow</a> by $233 billion since the November elections. &#8220;No wonder they were sitting right behind Donald Trump at his inauguration. They couldn't be happier,&#8221; he added.
Sanders also criticized Trump for <a href="https://www.benzinga.com/25/01/43087966/trump-signs-orders-to-take-us-out-of-paris-climate-agreement-calls-the-deal-one-sided-and-unfair">ignoring the climate crisis</a>, despite the worsening impact of extreme weather events worldwide. &#8220;Trump did not have one word to say about how we're going to address the planetary crisis of climate change. The last 10 years have been the warmest years ever recorded,&#8221; Sanders said, "except, of course, to make it clear that he intends to make this horrific situation even worse with <a href="https://www.benzinga.com/government/regulations/25/01/43097430/trumps-drill-baby-drill-era-begins-oil-prices-tumble-us-energy-stocks-edge-up">drill, baby, drill</a>. Just brilliant."
See Also: <a href="https://www.benzinga.com/money/mark-cubans-annuity-adv">Many are surprised by Mark Cuban's advice for lotto winners: Cash or annuity?</a>
<h2 class="wp-block-heading">A Call to Action</h2>
Sanders urged Americans to remain focused on the issues that truly matter to working families, including health care, affordable housing, climate change and income inequality. &#8220;Our job is to stay focused on the issues that are of importance to the working families of our country and in fact are widely supported by the American people,&#8221; he said.
He reiterated his long-standing policy proposals, including Medicare for All, lowering prescription drug costs, building affordable housing, and raising the federal minimum wage to $17 an hour. &#8220;Anybody who works 40 hours a week in this country should not be living in poverty,&#8221; Sanders stated firmly.
Sanders ended his remarks with a rallying cry for action, emphasizing the need for unity and grassroots organizing to counter Trump's agenda. &#8220;We cannot panic. No matter how many executive orders he signs and no matter how many absurd statements he makes, our goal remains the same. We have got to educate, we have got to organize, and we've got to put pressure on Congress to do the right things,&#8221; he said.
Read Next:
<ul>
<li>Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
</ul>

'How Crazy Is That,' Says Bernie Sanders, Condemning Trump For 'Ignoring' Working Families' Issues In His Inauguration Speech

Donald Trump's first week in the Oval Office proved to be a blockbuster one for the markets. The S&amp;P 500 surged 1.7%, delivering its best first-week performance under a new presidency since Ronald Reagan <a href="https://www.benzinga.com/25/01/43122112/us-stocks-likely-to-open-higher-as-president-trump-announces-500-billion-ai-project-oracle-netflix-nvidia-among-stocks-in-focus">took office in 1985</a>.
On Monday, Jan. 27, <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43244872/tech-stocks-tumble-on-ai-nightmare-nvidia-eyes-worst-day-since-march-2020-bitcoin-drops-below-100000-whats-driving-markets-monday">tech stocks plummeted</a>. On Tuesday, Wall Street <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43283732/tech-rebounds-after-black-monday-nvidia-rallies-6-gm-plummets-whats-driving-markets-tuesday">attempted a rebound</a>.
Whether this market trajectory will deplete or restore optimism around the corporate earnings season remains to be seen. In the meantime, here&#8217;s a look at three exchange-traded funds that <a href="https://www.benzinga.com/etfs">mirror the S&amp;P 500 Index</a>.
<ul>
<li>The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) holds 504 stocks across multiple sectors, including information technology, financials, consumer discretionary, and health care. With an AUM of $549.97 billion, SPY charges 0.09% in annual expense fees.</li>
<li>The Vanguard S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VOO#NYSE">VOO</a>), which comes with an expense ratio of a meager 0.02%, holds 505 stocks, and manages assets worth $472 billion.</li>
<li>iShares Core S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IVV#NYSE">IVV</a>), another popular choice, offers similar sector allocations and has an expense ratio of 0.03%.</li>
<li>Both VOO and IVV saw gains in line with SPY, as their diversified portfolios factored in the week's broader market rally.</li>
</ul>
<h1 class="wp-block-heading">What Moved The Markets?</h1>
Investors welcomed <a href="https://www.benzinga.com/markets/25/01/43219264/trumps-tariff-plans-ignite-market-rally-pushing-stocks-to-record-highs">Trump's proposal to cut the corporate tax rate</a> from 21% to 15%, expecting the move would drive business growth and investment within the U.S.
Trump also proposed raising taxes on businesses outside of the U.S., a move he said could bring "<a href="https://www.benzinga.com/news/global/25/01/43170854/trump-outlines-economic-reset-at-davos-5-things-you-need-to-know">hundreds of billions, even trillions" of dollars</a> into the economy and boost domestic manufacturing and job creation. Trump also focused on energy, urging OPEC to boost production and lower prices, while signing executive orders to expand U.S. oil and gas production. 
The <a href="https://www.benzinga.com/etfs/sector-etfs/25/01/43135764/trumps-500-billion-stargate-ai-plan-puts-3-etfs-in-focus">Stargate AI Infrastructure Project </a>was also introduced, which, backed by OpenAI, SoftBank and Oracle Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>), plans to invest up to $500 billion in building AI infrastructure across the U.S., with an initial commitment of $100 billion. This project has the potential to create 100,000 jobs, Trump said.
A strong start to the corporate earnings season also played a big role in the rally.
But on Monday, U.S. tech stocks plunged as word spread of China&#8217;s DeepSeek R1, <a href="https://www.benzinga.com/25/01/43232316/deepseek-jitters-shatter-us-tech-stocks-wipe-out-12-trillion-on-wall-street-analyst-eyes-four-chinese-giants-set-to-benefit">shaking investor confidence</a>.
<h1 class="wp-block-heading">The Stocks That Powered The ETFs</h1>
The ETFs saw gains across various sectors, but a handful of stocks stood out as top performers:
<ul>
<li>Moderna (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>): The pharmaceutical giant gained 21.6% last week, buoyed by its innovations in mRNA-based therapies.</li>
<li>Oracle: A key partner in the Stargate AI project, Oracle rose 14%.</li>
<li>Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>): The streaming stalwart also jumped 14% on strong results and upward revision in guidance.</li>
<li>Vistra Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VST#NYSE">VST</a>): The energy company climbed 11.8%, benefiting from bullish sentiments in the energy sector.</li>
<li>Amphenol Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APH#NYSE">APH</a>): Known for its high-tech interconnect systems, Amphenol rose 11.2%, boosted by a positive earnings revision.</li>
</ul>
See Next: 
<ul>
<li><a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/01/43253190/deepseek-ai-etfs-take-a-hard-hit-amid">DeepSeek AI Model Sends Shockwaves Through Nvidia, Slams ETFs</a></li>
</ul>
Photo: Shutterstock.

Broad U.S. Equity ETFs

ETFs

MRNA

NFLX

ORCL

3 ETFs Shine As Trump's First Week Sparks Record Gains Followed By Tech Slump

A new Benzinga reader poll shows a mixed opinion on whether users are headed for the exits of social media platforms in the months since the<a href="https://www.benzinga.com/news/24/11/41768178/donald-trump-defeats-kamala-harris-to-win-2024-election"> 2024 presidential election.</a>
While many users are staying on social media platforms, here's a look at which companies could be most impacted.
 What Happened: A recent email from X owner Elon Musk to his staff suggested the social media platform he paid $44 billion for might be <a href="https://www.benzinga.com/25/01/43204045/elon-musk-says-x-user-growth-is-stagnant-banks-who-financed-acquisition-selling-debt-at-10-discount">seeing slower growth</a> in the months since the 2024 election, which was won by Donald Trump. 
"Our user growth is stagnant, revenue is unimpressive, and we're barely breaking even," Musk said in the email.
The email comes months after Musk highlighted the record usage X saw during the presidential election.
"Over the last few months, we've witnessed the power of X in shaping the national conversations and outcomes. We are also seeing other platforms begin to adopt our commitment to free speech and unbiased truth," Musk also said in the email.
Benzinga recently asked readers if they were considering leaving social media platforms.
"Do you plan to stop using any of these social media platforms in the wake of the 2024 presidential election?" Benzinga asked.
Here are the results:
<ul>
<li>I don't plan to stop using any platforms: 53%</li>
<li>X (formerly Twitter): 18%</li>
<li>TikTok: 11%</li>
<li>Facebook: 8%</li>
<li>Instagram: 5%</li>
<li>Reddit: 3%</li>
<li>Snapchat: 2%</li>
</ul>
The poll found the majority wasen't leaving any of the mentioned social media platforms in the wake of the election won by Trump.
The company leading the platform votes was X, which could be in response to its ownership by Musk, a close ally of Trump. Musk has become more outspoken politically on the platform and there could be a belief that he will try to influence X users with his ideals.
Ranking second was TikTok, which faces <a href="https://www.benzinga.com/general/social-media/25/01/42957741/tiktok-ban-deadline-ahead-what-will-happen-to-app-on-your-phone">a pending ban</a> that Trump has paused with an executive order. Facebook and Instagram, which are owned by Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) ranked third and fourth, respectively, among social media platforms with a combined 13%. This could be bad news for the company as it could see an exodus of users in the coming months.
Reddit (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) and Snap Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNAP#NYSE">SNAP</a>)-owned Snapchat received a lower percentage of potential users leaving in the poll.
Read Also: <a href="https://www.benzinga.com/general/social-media/25/01/43149771/follow-biden-or-harris-on-instagram-facebook-chances-are-youre-now-following-trump-or-vance">Follow Biden Or Harris On Instagram, Facebook? Chances Are You&#8217;re Now Following Trump Or Vance</a>
Why It's Important: The poll saw the majority of users not exiting social media platforms could show that fears of users being influenced by politics and leaving platforms based on who owns them could be overblown.
There were reports that users on Facebook and Instagram could be leaving the platform after Meta's<a href="https://www.benzinga.com/25/01/42851889/meta-ditches-fact-checking-for-community-notes-zuckerberg-says-opportunity-to-restore-free-expression"> content moderation changes</a>. Searches for "delete Facebook" and "delete Instagram" have surged on Google in recent weeks, but the poll shows that users might not be ready to leave the platforms yet.
X leads the way for a potential trend of consumers <a href="https://www.benzinga.com/news/global/25/01/43172806/tesla-lost-15-billion-in-brand-value-in-2024-report-says-did-elon-musks-political-push-hurt-ev-giant">being less happy </a>with the brands associated with Musk as his political efforts ramp up.
Reports showed that users <a href="https://www.benzinga.com/general/social-media/24/12/42566461/mark-cuban-says-this-is-the-holy-grail-that-makes-bluesky-better-than-musks-x-platform">went to alternate platforms </a>like Bluesky after the election, but this poll could show that people never truly left or they didn&#8217;t stay on Bluesky.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/social-media/25/01/43176248/tiktok-ban-effect-smartphones-with-app-installed-hit-ebay">TikTok Ban Effect: Smartphones With App Installed Hit Ebay</a></li>
</ul>
The study was conducted by Benzinga from Jan. 25, 2025, through Jan. 27, 2025. It included the responses of a diverse population of adults 18 or older. Opting into the survey was completely voluntary, with no incentives offered to potential respondents. The study reflects results from 150 adults.
Photo: Farknot Architect/Shutterstock.com

Social Media

Exclusives

RDDT

SNAP

EXCLUSIVE: Will Social Media Users Leave Over Politics? New Poll Shows This Platform Hurt Most

When Netflix announced it was <a href="https://www.benzinga.com/25/01/43131519/ellison-envisions-tailored-cancer-vaccines-in-48-hours-amid-trumps-500b-ai-push-netflix-surges-15-on-price-hike-after-record-subscriber-growth-dogecoin-drops-7-top-headlines-while-the-us-slept">raising prices</a> again this week, the internet had much to say. But one of the funniest and most talked-about responses came from AriZona Iced Tea. The company, famous for its 99-cent cans, tweeted to remind everyone that while Netflix keeps charging more, their price hasn't changed.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">AriZona Iced Tea is still 99 cents <a href="https://t.co/Ih9ZAkjtZU">https://t.co/Ih9ZAkjtZU</a>
&mdash; AriZona Iced Tea (@DrinkAriZona) <a href="https://twitter.com/DrinkAriZona/status/1882181201987035591?ref_src=twsrc%5Etfw">January 22, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Don't Miss:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
<li><a href="https://www.benzinga.com/money/qnetic-2">This 12,000 RPM Spinning Battery With Over $100 Million In LOIs Could Be The Missing Link For Green Energy — Here&#8217;s Why Early Investors Are Flocking To Invest Before Funding Closes</a> </li>
</ul>
"AriZona Iced Tea is still 99 cents," the brand tweeted, earning over 14 million views. The playful dig at Netflix&#8217;s rising costs quickly went viral, with fans jumping into the conversation. One person joked, "Can you start a streaming service right now?" AriZona replied, "Yeah, I'm streaming some AriZona into my mouth right now." Someone else asked where they got their information, and AriZona simply said, "Me."
This funny back-and-forth highlights a real point: prices are going up everywhere, but AriZona is sticking to their 99-cent promise. They've kept the same price since 1992! Don Vultaggio, the founder of AriZona, says keeping the price low is important to him. "Why have people who are having a hard time paying their rent pay more for their drink?" he said. "Maybe it's my little way of giving back."
AriZona has managed to keep its price low through strategic decisions like thinner cans, optimized production and efficient shipping methods. "We make it faster. We ship it better. We ship it closer. The cans are thinner."
Trending: The Biggest Disruption To IP Since Disney — <a href="https://www.benzinga.com/money/elf-labs-1">Get in now as they monetize a $2 Trillion market by building content around the most profitable Character IP in history and combining it with the Patented Technology IP of the future.</a>
Unlike competitors who invest heavily in advertising, AriZona relies on word-of-mouth to grow its customer base. Despite inflation and rising costs over the years, the company remains debt-free and highly profitable, with Vultaggio's net worth surpassing $5.6 billion.
Meanwhile, <a href="https://www.benzinga.com/markets/equities/25/01/43119464/netflix-raises-prices-16-peter-schiff-warns-of-escalating-inflation-risks-ahead-of-trump-policies">Netflix's latest price increases –</a>$7.99 for its ad-supported plan (up $1), $17.99 for the standard plan without ads (up $2.5) and $24.99 for its premium plan (up $2) – arrived alongside strong earnings. The streaming giant added 19 million subscribers in the last quarter of 2024, bringing its global total to 302 million. The company says the extra money will go toward making more content, like the <a href="https://www.benzinga.com/general/sports/24/11/42022601/mike-tyson-vs-jake-paul-netflixs-explosive-boxing-event-ends-with-pauls-victory">Jake Paul vs. Mike Tyson boxing match</a> and new seasons of hits like <a href="https://www.benzinga.com/general/entertainment/24/12/42305013/squid-game-season-2-includes-new-games-contestant-with-a-crypto-background-revenge-factor-political-overtones">Squid Game</a>.
While Netflix continues to adjust its pricing strategy, AriZona's commitment to staying affordable has become a rare and refreshing constant. Judging by the overwhelming reaction to their tweet, it's clear that people appreciate their humor – and their prices. AriZona Iced Tea remains a steady, 99-cent bright spot in a world of <a href="https://www.benzinga.com/startups/24/11/42027079/we-will-pass-those-tariff-costs-back-to-the-consumer-says-ceo-of-autozone-heres-a-look-at-other-companies-raising-prices">ever-increasing costs</a>. Read Next:
<ul>
<li>According to Juniper Research, the total value of B2B cross-border payments stored on the blockchain is projected to exceed $4.4 trillion — <a href="https://www.benzinga.com/money/web3-enabler-future-of-enterprise-transactions">Join the first company to bring blockchain payments to Salesforce early with just $100.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
</ul>

AriZona Iced Tea Takes A Shot At Netflix For Raising Their Prices–'It's Still 99 Cents'

The fourth-quarter earnings season is in full swing, and <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/43054693/magnificent-7-earnings-hinge-on-ai-payoff-analyst-flags-top-risks">all eyes are on the Magnificent 7,</a> a group of tech giants that enjoy the market&#8217;s attention, thanks in part to the ongoing artificial intelligence boom and their dominance in this space.
These stocks are Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>), Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), NVIDIA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) and Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>). <a href="https://www.benzinga.com/etfs">ETFs that focus</a> heavily on these stocks have also become attractive options for investors seeking diversified exposure ahead of their earnings results.
If you're looking to ride the earnings wave, here are three ETFs worth considering:
The Roundhill Magnificent Seven ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAGS#NASDAQ">MAGS</a>) was the first ETF offering equal-weight exposure to these seven stocks. It has an expense ratio of 0.29% and an AUM of $639.75 million. The ETF has grown 61% in the last year.
For a slightly broader yet targeted approach, the MicroSectors FANG+ ETN (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FNGS#NYSE">FNGS</a>) could be a good choice. The fund tracks the NYSE FANG+ Index and maintains a 10% share in each of the seven stocks. The expense ratio is 0.58%.
Meanwhile, the Vanguard Mega Cap Growth ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MGK#NYSE">MGK</a>) allocates around 59% of its assets to the Magnificent 7. The ETF has $21.60 billion in AUM and an expense ratio of 0.06%, making this a pocket-friendly option.
<h1 class="wp-block-heading">What's Next For The Magnificent 7?</h1>
As the earnings season progresses, the Magnificent 7 stocks are expected to report earnings growth of 18% in 2025, marking a slowdown, according to a December 2024 report by Bloomberg. 
Tesla, Microsoft and Meta Platforms will kick off earnings with reports scheduled after market close on Wednesday. Apple follows Thursday, while Alphabet and Amazon are set to announce results on Feb. 4 and Feb. 6, respectively. Nvidia is likely to release its earnings later in February.
<a href="https://www.benzinga.com/25/01/43232316/deepseek-jitters-shatter-us-tech-stocks-wipe-out-12-trillion-on-wall-street-analyst-eyes-four-chinese-giants-set-" target="_blank" rel="noreferrer noopener">Hangzhou, China-based AI startup</a> DeepSeek launched a new AI model that poses a challenge to U.S. competitors, including Nvidia&#8217;s core business. Industry experts like venture capitalist Marc Andreessen called this moment a "Sputnik moment" for U.S. AI companies as this could be a ground-breaker in the AI space, reported Reuters.
Nvidia shares rebounded Tuesday after analysts called the&nbsp;market&#8217;s reaction an &#8220;overreaction.&#8221; Analysts believe advancements like these could drive even more investment in AI, which can be beneficial for companies including Nvidia. Moreover, Nvidia has already said that DeepSeek's inference requires &#8220;significant numbers of Nvidia GPUs and high-performance networking."
See Also: <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43283732/tech-rebounds-after-black-monday-nvidia-rallies-6-gm-plummets-whats-driving-marke">Tech Rebounds After Black Monday, Nvidia Rallies 6%, GM Plummets: What&#8217;s Driving Markets Tuesday?</a>
Tesla has faced mixed fortunes recently. The EV maker reclaimed its trillion-dollar market cap thanks to a favorable policy environment. Yet it hit a roadblock with its fourth-quarter delivery numbers. The company missed estimates and reported its first-ever year-over-year decline in full-year vehicle deliveries. 
Adding to the challenges, recent rollbacks of pro-EV policies weighed on Tesla's stock, which fell 2.5% year-to-date. Despite these shortfalls, Tesla's leadership in EV scale and technology gives it an edge, particularly in markets where tariffs might restrict cheaper imports from Chinese competitors.
Microsoft continues to shine as a key AI forerunner with substantial investments in data centers and AI development. The company expects $10 billion in AI-related revenues next quarter.
Meta looks promising, with analysts raising their price targets ahead of its earnings release. Wedbush and BofA Global Securities now peg Meta's stock at $700 and $710, respectively. The social media company expects to generate revenues of $45-$48 billion in the fourth quarter but also anticipates increased spending on AI and infrastructure projects. This might shrink the margins.
Despite rolling out new AI-driven applications late last year, Apple has struggled to gain momentum, particularly in international markets. Its latest iPhone 16 has seen muted sales. Jefferies recently downgraded Apple to Underperform. Looking ahead, Apple expects low to mid-single-digit sales growth in its fiscal first quarter.
Alphabet is currently staring at antitrust lawsuits and increasing competition in the generative AI space. Analysts remain concerned about the long-term impact of AI on Alphabet's core search business.
Amazon continues to dominate e-commerce and cloud computing, while its AI business is growing rapidly. The company's fourth-quarter revenues are projected to land between $181.5 billion and $188.5 billion. Amazon's investments in AI infrastructure, including data centers and custom chips, position it well for sustained growth in this sector.
See Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/upgrades/25/01/43284333/nvidia-positioned-for-400-billion-ai-boom-with-advanced-gpus-new-product-launches-drivin">Nvidia Positioned For $400 Billion AI Boom With Advanced GPUs, New Product Launches Driving Revenue Growth, Say Analysts</a></li>
</ul>
Photo: Shutterstock.

Sector ETFs

Tech

AAPL

AMZN

FNGS

GOOG

GOOGL

MAGS

MSFT

NVDA

TSLA

Magnificent 7 Earnings Ahead: 3 ETFs To Ride The Wave

Chain Bridge Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBNA#NYSE">CBNA</a>) reported quarterly earnings of $0.59 per share which beat the analyst consensus estimate of $0.55 by 7.27 percent.

Earnings Beats

CBNA

Chain Bridge Bancorp Q4 2024 GAAP EPS $0.59 Beats $0.55 Estimate

Paragon 28 has announced net revenue for the full year of 2024 to be in a range of $255.9 to $256.2 million, representing 18.2% to 18.4% reported growth over the prior fiscal year.&nbsp;
Zimmer Biomet expects the proposed transaction, considering the impact of financing, to be approximately 3% dilutive to adjusted earnings per share in 2025, about 1% dilutive to 2026 adjusted earnings per share and accretive to adjusted earnings per share within 24 months of deal close.
Zimmer Biomet plans to fund the proposed transaction through a combination of cash on the balance sheet and other available debt financing sources. Zimmer Biomet expects to maintain a strong balance sheet and to continue to support its stated capital allocation priorities.

Zimmer Biomet Expects Proposed Paragon 28 Transaction To Immediately Accelerate Revenue Growth And To Be Approximately 3% Dilutive To Adjusted EPS In 2025

Paragon 28 shareholders will also receive a non-tradeable contingent value right (CVR) entitling the holder to receive up to $1.00 per share in cash if certain revenue milestones are achieved.&nbsp;
The CVR will be payable in whole or in part if net sales exceed $346 million up to $361 million (with the CVR payments calculated linearly between $0.00 and $1.00 if net sales are between $346 million and $361 million) during Zimmer Biomet's fiscal year 2026.&nbsp;
The board of directors of each of Zimmer Biomet and Paragon 28 has unanimously approved the proposed transaction.
 &nbsp;

Zimmer Biomet To Acquire Paragon 28 For Upfront Payment Of $13.00 Per Share In Cash, Corresponding To An Equity Value Of $1.1B And Enterprise Value Of $1.2B

Jones Trading analyst Soumit Roy initiates coverage on OnKure Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKUR#NASDAQ">OKUR</a>) with a Buy rating and announces Price Target of $32.

Price Target

Initiation

Analyst Ratings

OKUR

Jones Trading Initiates Coverage On OnKure Therapeutics with Buy Rating, Announces Price Target of $32

Jefferies analyst Rob Dickerson maintains WK Kellogg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KLG#NYSE">KLG</a>) with a Hold and lowers the price target from $19 to $16.

Jefferies Maintains Hold on WK Kellogg, Lowers Price Target to $16

The Food and Drug Administration on Tuesday approved Ozempic, the weight loss drug made by Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>), for the treatment of chronic kidney disease in patients who also <a href="https://www.benzinga.com/25/01/42875977/novo-nordisk-seeks-to-strengthen-its-obesity-pipeline-with-back-to-back-two-biobuck-deals">have type 2 diabetes. </a>
The Details: According to the Centers for Disease Control and Prevention, more than 35.5 million Americans have chronic kidney disease, often as a complication of type 2 diabetes. The new FDA approval allows for further expansion of Ozempic's use and potential coverage by health insurance plans.&nbsp;
Read Next:<a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/43254018/sofi-stock-falls-on-soft-guidance-despite-strong-quarter-with-record-member-growth-loan-originations-analyst"> SoFi Stock Falls On Soft Guidance Despite &#8216;Strong Quarter&#8217; With Record Member Growth, Loan Originations: Analyst&nbsp;</a>
The FDA approval "allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of adults and could have serious consequences if left untreated," Anna Windle, a senior vice president at Novo Nordisk, said in a statement Tuesday, per a Bloomberg <a href="https://www.bloomberg.com/news/articles/2025-01-28/novo-s-ozempic-notches-approval-for-kidney-disease-widening-use?sref=TBDibEcD">report</a>.&nbsp;
Ozempic and other diabetes drugs known as GLP-1s have become popular and also well-known for their high cost.&nbsp;
Earlier in January, Novo Nordisk's diabetes and weight loss drugs, Ozempic, Rybelsus, and Wegovy were all added to the U.S. Department of Health and Human Services list of drugs covered under Medicare Part D that<a href="https://www.benzinga.com/25/01/43062779/popular-ozempic-wegovy-selected-for-next-round-of-medicare-drug-price-negotiations"> have been selected</a> for mandated price negotiations in order to reduce <a href="https://www.benzinga.com/general/biotech/24/08/40534249/novo-nordisks-ozempic-might-be-among-2027-medicare-price-negotiation-targets">prescription drug costs</a>.
The negotiations will take place in 2025, with the new prices slated to take effect in 2027.
NVO Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Novo Nordisk shares ended Tuesday's session down 2.65% at $85.19.&nbsp;
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/25/01/43287988/microsoft-q2-preview">Microsoft Q2 Earnings Preview: Street &#8216;Too Optimistic&#8217; On Near-Term AI Returns?&nbsp;</a></li>
</ul>
Photo: Shutterstock

Biotech

Ozempic Receives FDA Approval To Treat Kidney Disease

Trading Halt: Halt status updated at 5:50:00 PM ET: Quotation Resumption: News and Resumption Times

Finward Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FNWD#NASDAQ">FNWD</a>) reported quarterly earnings of $0.49 per share which beat the analyst consensus estimate of $0.20 by 145 percent. This is a 40 percent increase over earnings of $0.35 per share from the same period last year. The company reported quarterly sales of $16.34 million which beat the analyst consensus estimate of $16.00 million by 2.12 percent. This is a 5.75 percent increase over sales of $15.45 million the same period last year.

FNWD

Finward Bancorp Q4 2024 GAAP EPS $0.49 Beats $0.20 Estimate, Sales $16.34M Beat $16.00M Estimate

Compass Point analyst Giuliano Bologna upgrades Affirm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) from Sell to Neutral and raises the price target from $20 to $61.

Upgrades

AFRM

Compass Point Upgrades Affirm Holdings to Neutral, Raises Price Target to $61

The options include a possible sale of the company, business combination, sale of all or part of the Company's assets, licensing of assets, restructuring, or other strategic action.

23andMe Reveals Process To Explore Strategic Alternatives

Compass Point analyst Joe Flynn initiates coverage on Applied Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLD#NASDAQ">APLD</a>) with a Buy rating and announces Price Target of $10.

APLD

Compass Point Initiates Coverage On Applied Digital with Buy Rating, Announces Price Target of $10

Press Releases

Compass Therapeutics to Participate in the Wedbush PacGrow Healthcare Conference

Compass Therapeutics Reports 2024 Second Quarter Financial Results and Provides Corporate Update

Compass Therapeutics to Participate in Upcoming Investor Events

Compass Therapeutics Announces Upcoming Poster Presentation at the 39th Society for Immunotherapy of Cancer Annual Meeting

Compass Therapeutics Presents Novel Biomarker Data Related to CTX-471 Clinical Activity at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

Compass Therapeutics Reports 2024 Third Quarter Financial Results and Provides Corporate Update

Compass Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference

Management

Compass Therapeutics Appoints Biopharmaceutical Industry Leader Barry Shin as Chief Financial Officer

Compass Therapeutics Provides Corporate Update and Announces Advancement of a New Drug Candidate

Comments

Compass Therapeutics

Compass Therapeutics (CMPX) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga